✦ LIBER ✦

CD56 expression in a case of primary cutaneous CD30+ anaplastic large cell lymphoma

✍ Scribed by S-E. Chang; I-J. Park; J. Huh; J-H. Choi; K-J. Sung; K-C. Moon; J-K. Koh

Publisher: John Wiley and Sons
Year: 2000
Tongue: English
Weight: 550 KB
Volume: 142
Category: Article
ISSN: 0007-0963
DOI: 10.1046/j.1365-2133.2000.03423.x

No coin nor oath required. For personal study only.

✦ Synopsis

We describe clinicopathological features of an unusual case of CD30+/CD56+ T-cell lymphoma in a 58-year-old Korean man who presented with disseminated nodules, papules and hyperpigmented patches. Coexpression of CD30 and CD56 in T-cell lymphoma is very rare. Our patient did not respond to an intensive chemotherapy regimen, in contrast to the previously reported cases of primary cutaneous CD30+ anaplastic large cell lymphoma. Coexpression of CD56 might therefore identify a subset of CD30+ lymphomas with more aggressive features.

📜 SIMILAR VOLUMES

Genetic alterations in primary cutaneous

Genetic alterations in primary cutaneous CD30+ anaplastic large cell lymphoma

✍ Xin Mao; Guy Orchard; Debra M. Lillington; Robin Russell-Jones; Bryan D. Young; 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 731 KB

## Abstract Primary cutaneous CD30+ anaplastic large cell lymphoma (C‐ALCL) represents a distinct clinical subtype of CD30+ anaplastic large cell lymphomas. The etiology and underlying molecular pathogenesis of C‐ALCL remain unclear. This study aimed to investigate genetic changes in C‐ALCL. Compar

CD30+ lymphoproliferative disorder: prim

CD30+ lymphoproliferative disorder: primary cutaneous anaplastic large cell lymphoma followed by lymphomatoid papulosis

✍ M. Aoki; Y. Niimi; S. Takezaki; A. Azuma; M. Seike; S. Kawana 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 494 KB

CD30+ anaplastic large-cell lymphoma wit

CD30+ anaplastic large-cell lymphoma with aberrant expression of CD13: Case report and review of the literature

✍ Cherie H. Dunphy; Laura J. Gardner; Jose L. Manes; Christopher S. Bee; Kutay Tay 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 679 KB

CD13 is commonly expressed in hematopoietic malignancies of myelomonocytic origin and has less commonly been described in lymphoid neoplasms, including acute lymphoblastic leukemia, B-cell lymphoproliferative disorders, and plasma cell malignancies. Aberrant CD13 expression has rarely been described

Rare occurrence of CD30+ circulating cel

Rare occurrence of CD30+ circulating cells in patients with cutaneous CD30+ anaplastic large cell lymphoma: a study of nine patients

✍ O. Dereure; P. Portales; M. Balavoine; P. Corbeau; B. Guillot; J. Clot; J-J. Gui 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

## Background: The presence of a significant percentage of circulating atypical lymphocytes in peripheral blood has already been demonstrated in systemic cd30+ anaplastic large cell lymphoma (alcl), which implies that a leukaemic component may be present in this subset of lymphomas. however, no sim

Primary Ki-1 (CD 30)–positive, large cel

Primary Ki-1 (CD 30)–positive, large cell, anaplastic lymphoma of the esophagus

✍ Jonathan M. Pearson; A. Borg-Grech 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 415 KB 👁 2 views

Childhood anaplastic large cell lymphoma

Childhood anaplastic large cell lymphoma Ki-1/CD30: Clinicopathologic features of 19 cases

✍ Rubie, Hervé ;Gladieff, Laurence ;Robert, Alain ;Gaubert, Isabelle ;Huguet, Fran 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 605 KB

## Abstract The authors report their cumulative experience of 19 children with what was previously called malignant histiocytosis (MH) but is now considered a true lymphoma and termed anaplastic large cell lymphoma (ALCL). The median age at diagnosis was 10 years and 6 months (range 2 y, 11 m, to 1